Search Results - "HARTMANN, Arndt"

Refine Results
  1. 1
  2. 2
  3. 3

    Deep Learning Predicts Molecular Subtype of Muscle-invasive Bladder Cancer from Conventional Histopathological Slides by Woerl, Ann-Christin, Eckstein, Markus, Geiger, Josephine, Wagner, Daniel C., Daher, Tamas, Stenzel, Philipp, Fernandez, Aurélie, Hartmann, Arndt, Wand, Michael, Roth, Wilfried, Foersch, Sebastian

    Published in European urology (01-08-2020)
    “…Muscle-invasive bladder cancer (MIBC) is the second most common genitourinary malignancy, and is associated with high morbidity and mortality. Recently,…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    IL-9 and its receptor are predominantly involved in the pathogenesis of UC by Nalleweg, Nancy, Chiriac, Mircea Teodor, Podstawa, Eva, Lehmann, Christian, Rau, Tilman T, Atreya, Raja, Krauss, Ekaterina, Hundorfean, Gheorghe, Fichtner-Feigl, Stefan, Hartmann, Arndt, Becker, Christoph, Mudter, Jonas

    Published in Gut (01-05-2015)
    “…Several pathogenic roles attributed over the past two decades to either T helper (Th)1 or Th2 cells are increasingly becoming associated with interleukin…”
    Get more information
    Journal Article
  7. 7
  8. 8
  9. 9

    Pathology and systemic therapy of non-clear cell renal cell carcinoma: an overview by Bergmann, Lothar, Weber, Sarah, Hartmann, Arndt, Ahrens, Marit

    Published in Expert review of anticancer therapy (02-11-2021)
    “…Introduction: Non-clear cell renal cell carcinoma (nccRCC) represents a highly heterogenous group of kidney cancer entities. As most clinical trials…”
    Get full text
    Journal Article
  10. 10

    Reduced Expression of miRNA-27a Modulates Cisplatin Resistance in Bladder Cancer by Targeting the Cystine/Glutamate Exchanger SLC7A11 by DRAYTON, Ross M, DUDZIEC, Ewa, PETER, Stefan, BERTZ, Simone, HARTMANN, Arndt, BRYANT, Helen E, CATTO, James WF

    Published in Clinical cancer research (01-04-2014)
    “…Resistance to cisplatin-based chemotherapy is a major obstacle to bladder cancer treatment. We aimed to identify microRNAs (miRNA) that are dysregulated in…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Misleading Germ Cell Phenotype in Pulmonary NUT Carcinoma Harboring the ZNF532-NUTM1 Fusion by Agaimy, Abbas, Haller, Florian, Renner, André, Niedermeyer, Jost, Hartmann, Arndt, French, Christopher A.

    Published in The American journal of surgical pathology (01-02-2022)
    “…NUT carcinoma (aka NUT midline carcinoma) is a rare, still significantly underrecognized aggressive malignancy. Although historically considered a midline…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Complement Activation via the Lectin and Alternative Pathway in Patients With Severe COVID-19 by Niederreiter, Janina, Eck, Christine, Ries, Tajana, Hartmann, Arndt, Märkl, Bruno, Büttner-Herold, Maike, Amann, Kerstin, Daniel, Christoph

    Published in Frontiers in immunology (02-02-2022)
    “…Complement plays an important role in the direct defense to pathogens, but can also activate immune cells and the release of pro-inflammatory cytokines…”
    Get full text
    Journal Article
  17. 17

    Pancreatic undifferentiated rhabdoid carcinoma: KRAS alterations and SMARCB1 expression status define two subtypes by Agaimy, Abbas, Haller, Florian, Frohnauer, Judith, Schaefer, Inga-Marie, Ströbel, Philipp, Hartmann, Arndt, Stoehr, Robert, Klöppel, Günter

    Published in Modern pathology (01-02-2015)
    “…Pancreatic undifferentiated carcinoma is a heterogeneous group of neoplasms, including pleomorphic giant cell, sarcomatoid, round cell, and rhabdoid…”
    Get full text
    Journal Article
  18. 18

    WHO 2022 landscape of papillary and chromophobe renal cell carcinoma by Lobo, João, Ohashi, Riuko, Amin, Mahul B, Berney, Daniel M, Compérat, Eva M, Cree, Ian A, Gill, Anthony J, Hartmann, Arndt, Menon, Santosh, Netto, George J, Raspollini, Maria R, Rubin, Mark A, Tan, Puay Hoon, Tickoo, Satish K, Tsuzuki, Toyonori, Turajlic, Samra, Zhou, Ming, Srigley, John R, Moch, Holger

    Published in Histopathology (01-10-2022)
    “…The 5th edition of the WHO Classification of Tumours of the Urinary and Male Genital Systems contains relevant revisions and introduces a group of molecularly…”
    Get full text
    Journal Article
  19. 19

    SMARCA4 and SMARCA2 Deficiency in Non-small Cell Lung Cancer: Immunohistochemical Survey of 316 Consecutive Specimens by Herpel, Esther, MD, Rieker, Ralf J., MD, Dienemann, Hendrik, MD, Muley, Thomas, PhD, Meister, Michael, PhD, Hartmann, Arndt, MD, Warth, Arne, MD, Agaimy, Abbas, MD

    Published in Annals of diagnostic pathology (01-02-2017)
    “…Abstract The chromatin remodeling Switch Sucrose Non-Fermentable (SWI/SNF) complex has been increasingly implicated in the pathogenesis and dedifferentiation…”
    Get full text
    Journal Article
  20. 20